Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Did PacBio Just Sorta Sell Itself To Roche?
Seeking Alpha
Thursday, September 26, 2013 - 10:01am
tags:
Pacific Biosciences, Roche
Verastem Initiates Phase 2 Trial of Defactinib in Lung Cancer
Yahoo
Thursday, September 26, 2013 - 9:48am
tags:
Defactinib, Verastem, non-small cell lung cancer
Galena: Acquisition Prospects And Exciting Catalysts
Seeking Alpha
Thursday, September 26, 2013 - 9:12am
tags:
Galena Biopharma, stock offering, M&A, AstraZeneca
Stryker, Medtronic lose preemption bids in OP-1, Calstrux and Infuse lawsuit
Mass Device
Thursday, September 26, 2013 - 8:55am
tags:
Stryker, Medtronic, Calstrux, infuse, bone growth proteins, devices
Sanofi starts work on $95 mln Algerian plant, biggest in Africa
Reuters
Thursday, September 26, 2013 - 8:52am
tags:
Africa, Sanofi, drug manufacturing
VIVUS' Hopes Tied to Qsymia
Yahoo/Zacks
Thursday, September 26, 2013 - 8:51am
tags:
Vivus, Qsymia, obesity
Some Speculative Biotechs Making Major Moves
Seeking Alpha
Thursday, September 26, 2013 - 8:50am
tags:
Dynavax, Omeros, Pacific Biosciences
Ex-CEO of Amgen, Kevin Sharer, on Leadership
Harvard Business Review
Thursday, September 26, 2013 - 8:21am
tags:
Amgen, Leadership, Pharma CEOs, Kevin Sharer
Exelixis achieves enrollment target for phase 3 trial of cabozantinib
Yahoo/Fly on the Wall
Thursday, September 26, 2013 - 8:19am
tags:
Exelixis, cabozantinib, metastatic castration-resistant prostate cancer
What Side Effects? Drug Ads With Warnings May Spur More Sales
Pharmalot
Thursday, September 26, 2013 - 8:17am
tags:
drug ads, side effects, warnings
Lilly drug fails in breast cancer, succeeds in gastric cancer
Reuters
Thursday, September 26, 2013 - 8:14am
tags:
Eli Lilly, gastric cancer, breast cancer, ramucirumab
Novartis says "deep regret" over Japan drug trials scandal
Reuters
Thursday, September 26, 2013 - 8:13am
tags:
Novartis, Japan, clinical trials
Does Conatus Pharmaceuticals Have A Winner With Emricasan?
Seeking Alpha
Thursday, September 26, 2013 - 8:12am
tags:
Conatus Pharmaceuticals, emricasan, Gilead, Merck, Pfizer, liver disease, Sunesis, apoptosis
Does Merck's R&D Program Need a Wake-Up Call?
Motley Fool
Thursday, September 26, 2013 - 8:09am
tags:
R&D, Merck, drug approvals, sugammadex, Pfizer, Eli Lilly, Sanofi, AstraZeneca
Will 3 Versions of Pfizer Be More Valuable Than 1?
Motley Fool
Wednesday, September 25, 2013 - 3:16pm
tags:
Pfizer, spinoffs, Zoetis
Pacific Biosciences Rockets on Roche Diagnostics Deal
Motley Fool
Wednesday, September 25, 2013 - 1:11pm
tags:
Roche, diagnostics, Pacific Biosciences
FierceBiotech's 2013 Fierce 15
Fierce Biotech
Wednesday, September 25, 2013 - 1:04pm
tags:
biotech, AnaptysBio, Acetylon Pharmaceuticals, CytomX, Immunocore, FibroGen, Jounce Therapeutics, Kala Pharmaceuticals, Macrogenics, Moderna Therapeutics, Presage Biosciences, Nimbus Discovery, Scioderm, Ultragenyx, uniQure, Visterra
A Closer Look at 4 Pharmaceutical Giants
Motley Fool
Wednesday, September 25, 2013 - 11:02am
tags:
Merck, Pfizer, JNJ, GSK
Infinity Pharma's cancer drug fails mid-stage trial goals
Reuters
Wednesday, September 25, 2013 - 10:41am
tags:
Infinity Pharma, non-small cell lung cancer, retaspimycin
Novo Nordisk And A Questionable Form Of Victoza Promotion?
Pharmalot
Wednesday, September 25, 2013 - 10:35am
tags:
Novo Nordisk, Victoza, diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.